Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Early Phase Clinical Trials ◽

Stimulating Factor ◽

Receptor Inhibitor

PHASE II TRIAL OF THE PHOSPHATIDYINOSITOL-3 KINASE (PI3K) INHIBITOR BUPARLISIB (BKM120) IN RECURRENT GLIOBLASTOMA CONDUCTED BY THE IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM

Neuro-Oncology ◽

10.1093/neuonc/nou209.20 ◽

2014 ◽

Vol 16 (suppl 3) ◽

pp. iii47-iii47 ◽

Cited By ~ 7

Author(s):

P. Y. Wen ◽

W. K. A. Yung ◽

I. K. Mellinghoff ◽

S. Ramkissoon ◽

...

Keyword(s):

Clinical Trials ◽

Phase Ii ◽

Early Phase ◽

Phase Ii Trial ◽

Recurrent Glioblastoma ◽

Pi3k Inhibitor ◽

Early Phase Clinical Trials

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Cytotherapy ◽

10.3109/14653240903121245 ◽

2009 ◽

Vol 11 (8) ◽

pp. 992-1001 ◽

Cited By ~ 81

Author(s):

Stefan Fruehauf ◽

Marlon Romano Veldwijk ◽

Timon Seeger ◽

Mario Schubert ◽

Stephanie Laufs ◽

...

Keyword(s):

Progenitor Cells ◽

Phase Ii ◽

Peripheral Blood ◽

Phase Ii Study ◽

Peripheral Blood Progenitor Cells ◽

Stimulating Factor ◽

Factor G

A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2014.974049 ◽

2014 ◽

Vol 56 (6) ◽

pp. 1878-1880 ◽

Cited By ~ 3

Author(s):

Paolo Strati ◽

Wei-Gang Tong ◽

Candida Vitale ◽

William G. Wierda ◽

Susan O’Brien ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Phase Ii ◽

Phase Ii Study ◽

Lymphocytic Leukemia ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: A high-activity, dose-dense weekly regimen for advanced breast cancer

Annals of Oncology ◽

10.1023/a:1008324329562 ◽

1999 ◽

Vol 10 (8) ◽

pp. 937-942 ◽

Cited By ~ 27

Author(s):

C. Nisticò ◽

C. Garufi ◽

S. Barni ◽

L. Frontini ◽

D.A.P. Gallà ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

High Activity ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Dose Dense ◽

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdf150 ◽

2002 ◽

Vol 13 (6) ◽

pp. 889-894 ◽

Cited By ~ 8

Author(s):

R.H. De Boer ◽

T.G. Eisen ◽

P.A. Ellis ◽

S.R.D. Johnston ◽

G. Walsh ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Breast ◽

Phase II study of granulocyte-macrophage colony stimulating factor (GM-CSF) plus thalidomide in patients (pts) with hormone naïve adenocarcinoma of the prostate

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4743 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4743-4743 ◽

Cited By ~ 1

Author(s):

J. Hernandez ◽

R. J. Amato

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gm Csf ◽

Adenocarcinoma Of The Prostate ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma

Cancer ◽

10.1002/cncr.11829 ◽

2003 ◽

Vol 98 (12) ◽

pp. 2592-2598 ◽

Cited By ~ 66

Author(s):

William K. Oh ◽

Susan Halabi ◽

W. Kevin Kelly ◽

Cary Werner ◽

Paul A. Godley ◽

...

Keyword(s):

Phase Ii ◽

Prostate Carcinoma ◽

Phase Ii Study ◽

Hormone Refractory ◽

Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma: Results of a Phase II Study

Clinical Lymphoma ◽

10.3816/clm.2003.n.017 ◽

2003 ◽

Vol 4 (2) ◽

pp. 93-98 ◽

Cited By ~ 15

Author(s):

Stephanie A. Gregory ◽

Delvyn C. Case ◽

Linda Bosserman ◽

Debra L. Litwak ◽

William R. Berry ◽

...

Keyword(s):

Phase Ii ◽

Hodgkin’S Lymphoma ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Phase II study of intensive CEV (Carboplatin, Epirubicin and VP-16) Plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer

European Journal of Cancer ◽

10.1016/0959-8049(95)00403-3 ◽

1995 ◽

Vol 31 (13-14) ◽

pp. 2424-2426 ◽

Cited By ~ 4

Author(s):

C. Gridelli ◽

F. Perrone ◽

M. D'Aprile ◽

A. Rossi ◽

S. Palmeri ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Phase II Study of Combination Thalidomide/Interleukin-2 Therapy Plus Granulocyte Macrophage-Colony Stimulating Factor in Patients With Metastatic Renal Cell Carcinoma

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31815e4505 ◽

2008 ◽

Vol 31 (3) ◽

pp. 237-243 ◽

Cited By ~ 15

Author(s):

Robert J. Amato ◽

Rahul Malya ◽

Anish Rawat

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Phase Ii Study ◽

Interleukin 2 ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽